andromeda: daratumumab & cybord for newly diagnosed al amyloidosis
Published 4 years ago • 500 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
2:36
andromeda: daratumumab cybord for al amyloidosis
-
4:30
andromeda: daratumumab for al amyloidosis
-
3:56
andromeda: daratumumab plus vcd in al amyloidosis
-
5:07
daratumumab in the management of al amyloidosis
-
0:54
the potential of daratumumab alone or with cybord in patients with stage iv al amyloidosis
-
2:00
andromeda trial: d-vcd versus vcd in the treatment of patients with newly diagnosed al amyloidosis
-
1:21
andromeda study: updated safety run-in results
-
0:53
redefining the standard of care in al amyloidosis
-
12:00
uncovering new biomarkers for rcc: a review of emerging techniques
-
52:19
improving vision with non-invasive bioelectricity – a new hope
-
3:10
what is al amyloidosis?
-
2:41
optimizing the use of daratumumab in al amyloidosis
-
2:54
main results from the andromeda study
-
1:20
phase ii study investigating the efficacy of daratumumab in patients with stage 3b al amyloidosis
-
5:14
current status & updates in the management of al amyloidosis
-
1:03
real-world management of patients with al amyloidosis
-
2:46
single use daratumumab for al amyloidosis
-
3:07
daratumumab-based frontline therapy in al amyloidosis: real-world mayo clinic experience
-
1:53
altitude: venetoclax, daratumumab, and dexamethasone in systemic al amyloidosis with t(11;14)
-
1:06
daratumumab and carfilzomib for al amyloid neuropathy
-
1:45
real-world data in guiding amyloidosis treatment
-
4:10
updates in al amyloidosis